Given the finding that TTP loss occurs early in PCa development, we used genetically engineered mouse models (GEMMs) to investigate the impact of TTP loss in combination with PTEN loss on prostate epithelial cell transformation to cancer. The gene discussed is ZFP36; the disease is cancer.